References
- Asplund J. The uterine cervix and isthmus under normal and pathological conditions. Acta Radiol 1952; 91: 1
- Csapo A. I., Pulkkinen M. O. The mechanism of prostaglandin action on the pregnant human uterus. Prostaglandins 1979; 17: 283
- Csapo A. I., Puri C. P., Tarro S. Deactivation of the uterus during premature labor and term by the calcium antagonist nicardipine, In press
- Wiqvist N., Widholm O., Nillius S. J., Nilsson B. Dysmenorrhea and Prostaglandins. Acta Obstet Gynecol Scand Suppl 1979; 87
- Garfield R. E., Hayashi R. H. Presence of gap junctions in the myometrium of women during various stages of menstruation. Am J Obstet Gynecol 1980; 138: 369
- Garfield R. E., Kannan M. S., Daniel E. E. Gap junction formation in myometrium: Control by estrogens, progesterone and prostaglandins. Am J Physiol 1980; 238: C81
- Halbert D. R., Demers L. M., Jones D. E. D. Dysmenorrhea and prostaglandins. Obstet Gynecol Surv 1976; 31: 77
- Haukkamaa M., Luukkainen T., Timonen H. The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle. Ann Clin Res 1974; 6: 40
- Labrum A. H., Lipkin M., Dray F. Hyperprostaglandinemia. A previously unrecognized syndrome. International Conference on Prostaglandins, Florence, 1975; 222
- Lundström V. The role of prostaglandins in primary dysmenorrhea. Biochemical, pathophysiological and clinical aspects. Thesis, Karolinska Institutet, StockholmSweden 1977
- Pulkkinen M. O. Suppression of uterine activity by prostaglandin synthetase inhibitors. Acta Obstet Gynecol Scand Suppl 1979; 87: 39
- Torok I., Csapo A. I. The effects of progesterone, prostaglandin F2α and oxytocin on the calcium-activation of the uterus. Prostaglandins 1976; 12: 253
- Ulmsten U., Anderson K.-E., Forman A. Relaxing effects of nifedipine on the nonpregnant human uterus in vitro and in vivo. Obstet Gynecol 1978; 52: 436
- Wakeling A. E., Wyngarden L. J. Prostaglandin receptors in the human, monkey and hamster uterus. Endocrinology 1974; 95: 35
- Walker S. M. In vitro synthesis of prostaglandin F2α by human endometrium. Abstracts of the XXI British Congress of Obstetrics and Gynaecology, Sheffield, 1977; 37
- Warren N. L., Hawker R. W. Blood oxytocin in dysmenorrhea. Aust NZ J Obstet Gynaecol 1967; 7: 78
- Wilhelmsson L., Lindblom B., Wikland M., Hamberger L., Norström A., Wiqvist N. PGI2 may play a role in the pathophysiology of dysmenorrhea. Acta Obstet Gynecol Scand Suppl
- Wiqvist N. E., Lindblom B., Wilhelmsson L. The pathophysiology of primary dysmenorrhea. Res Clin Forums 1979; I: 47
- Ylikorkala O., Dawood M. Y. New concepts in dysmenorrhea. Am J Obstet Gynecol 1978; 130: 833
- Ylikorkala O., Puolakka J., Kauppila A. Serum gonadotrophins, prolactin and ovarian steroids in primary dysmenorrhea. Br J Obstet Gynaecol 1979; 86: 648
- Åkerlund M. Pathophysiology of dysmenorrhea. Acta Obstet Gynecol Scand Suppl 1979; 87: 27
- Åkerlund M., Strömberg P., Forsling M. L. Primary dysmenorrhea and vasopressin. Br J Obstet Gynaecol 1979; 86: 484